These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 28856092

  • 1. Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals.
    Lowe VJ, Lundt E, Knopman D, Senjem ML, Gunter JL, Schwarz CG, Kemp BJ, Jack CR, Petersen RC.
    Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
    [Abstract] [Full Text] [Related]

  • 2. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM, Laymon CM, Cohen AD, Zhang Z, Price JC, Boudhar S, McDade E, Aizenstein HJ, Klunk WE, Mathis CA.
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [Abstract] [Full Text] [Related]

  • 3. Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B.
    Adamczuk K, Schaeverbeke J, Nelissen N, Neyens V, Vandenbulcke M, Goffin K, Lilja J, Hilven K, Dupont P, Van Laere K, Vandenberghe R.
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):142-151. PubMed ID: 26260650
    [Abstract] [Full Text] [Related]

  • 4. Increased Pittsburgh Compound-B Accumulation in the Subcortical White Matter of Alzheimer's Disease Brain.
    Wakabayashi Y, Ishii K, Hosokawa C, Hyodo T, Kaida H, Yamada M, Yagyu Y, Tsurusaki M, Kozuka T, Sugimura K, Murakami T.
    Kobe J Med Sci; 2017 Mar 13; 62(5):E136-E141. PubMed ID: 28289271
    [Abstract] [Full Text] [Related]

  • 5. White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition.
    Lowe VJ, Lundt ES, Senjem ML, Schwarz CG, Min HK, Przybelski SA, Kantarci K, Knopman D, Petersen RC, Jack CR.
    J Nucl Med; 2018 Oct 13; 59(10):1583-1589. PubMed ID: 29674420
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 11C-Pittsburgh Compound B and 18F-Flutemetamol White Matter Binding in PET.
    Zeydan B, Schwarz CG, Przybelski SA, Lesnick TG, Kremers WK, Senjem ML, Kantarci OH, Min PH, Kemp BJ, Jack CR, Kantarci K, Lowe VJ.
    J Nucl Med; 2022 Aug 13; 63(8):1239-1244. PubMed ID: 34916245
    [Abstract] [Full Text] [Related]

  • 7. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC.
    Brain; 2008 Mar 13; 131(Pt 3):665-80. PubMed ID: 18263627
    [Abstract] [Full Text] [Related]

  • 8. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.
    Hatashita S, Yamasaki H, Suzuki Y, Tanaka K, Wakebe D, Hayakawa H.
    Eur J Nucl Med Mol Imaging; 2014 Feb 13; 41(2):290-300. PubMed ID: 24085503
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
    Okada Y, Kato T, Iwata K, Kimura Y, Nakamura A, Hattori H, Toyama H, Ishii K, Ishii K, Senda M, Ito K, Iwatsubo T, Japanese Alzheimer’s Disease Neuroimaging Initiative.
    Ann Nucl Med; 2020 Feb 13; 34(2):108-118. PubMed ID: 31749127
    [Abstract] [Full Text] [Related]

  • 10. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
    Ikonomovic MD, Buckley CJ, Abrahamson EE, Kofler JK, Mathis CA, Klunk WE, Farrar G.
    Acta Neuropathol; 2020 Oct 13; 140(4):463-476. PubMed ID: 32772265
    [Abstract] [Full Text] [Related]

  • 11. Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia.
    Rowe CC, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, Cselényi Z, Masters CL, Villemagne VL.
    J Nucl Med; 2013 Jun 13; 54(6):880-6. PubMed ID: 23575995
    [Abstract] [Full Text] [Related]

  • 12. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
    Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R.
    Neuroimage; 2013 Apr 15; 70():423-33. PubMed ID: 23261639
    [Abstract] [Full Text] [Related]

  • 13. Decreased Gray-White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea.
    Ylä-Herttuala S, Hakulinen M, Poutiainen P, Lötjönen J, Könönen M, Gröhn H, Vanninen R, Mussalo H, Laitinen T, Mervaala E.
    J Prev Alzheimers Dis; 2022 Apr 15; 9(3):499-506. PubMed ID: 35841251
    [Abstract] [Full Text] [Related]

  • 14. 18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.
    Higashi T, Nishii R, Kagawa S, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H.
    Ann Nucl Med; 2018 Apr 15; 32(3):206-216. PubMed ID: 29388083
    [Abstract] [Full Text] [Related]

  • 15. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
    Meyer PT, Hellwig S, Amtage F, Rottenburger C, Sahm U, Reuland P, Weber WA, Hüll M.
    J Nucl Med; 2011 Mar 15; 52(3):393-400. PubMed ID: 21321269
    [Abstract] [Full Text] [Related]

  • 16. Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.
    Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust WJ, Alzheimer’s Disease Neuroimaging Initiative.
    Eur J Nucl Med Mol Imaging; 2014 Jul 15; 41(7):1398-407. PubMed ID: 24647577
    [Abstract] [Full Text] [Related]

  • 17. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J, Iida H, Kishimoto T, Nagatsuka K.
    Neuroimage Clin; 2017 Jul 15; 13():209-214. PubMed ID: 28003959
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW, Chau ACM, Chiu PK, Shea YF, Kwan JSK, Chan FHW, Mak HK.
    J Alzheimers Dis; 2021 Jul 15; 79(2):819-832. PubMed ID: 33361593
    [Abstract] [Full Text] [Related]

  • 19. Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias.
    Son HJ, Oh JS, Roh JH, Seo SW, Oh M, Lee SJ, Oh SJ, Kim JS.
    Eur J Nucl Med Mol Imaging; 2019 Feb 15; 46(2):357-366. PubMed ID: 30109402
    [Abstract] [Full Text] [Related]

  • 20. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
    Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2016 Aug 15; 43(9):1686-99. PubMed ID: 26996778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.